X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202136
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-gets-usfda-nod-for-antiviral-drug-used-in-hiv-treatment/articleshow/106020624.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-usfda-nod-for-hiv-drug/articleshow/105586693.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206288
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211578
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210677
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210677
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215389
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214085
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-usfda-nod-for-generic-hiv-drug/articleshow/94639795.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.bseindia.com/xml-data/corpfiling/AttachLive/cb79b842-3bf4-438d-a183-e6553f9716b0.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215389
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206288
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-symtuza-210455-darunavir-cobicistat-emtricitabine-tenofovir-alefenamide-80mg-150mg-200mg-10mg-tablets-1633682776.pdf
https://www.empr.com/home/news/safety-alerts-and-recalls/counterfeit-hiv-drug-identified-in-three-us-pharmacies/
https://www.empr.com/home/news/safety-alerts-and-recalls/counterfeit-hiv-drug-identified-in-three-us-pharmacies/
https://www.jnj.com/lack-of-evidence-to-support-darunavir-based-hiv-treatments-for-coronavirus
https://www.reuters.com/article/us-healthcare-coronavirus-johnson-johnso/johnson-johnson-says-no-evidence-hiv-drug-works-against-coronavirus-idUSKBN21327V?feedType=RSS&feedName=healthNews
https://cen.acs.org/sections/coronavirus/biological-chemistry/infectious-disease/coronavirus-drug-repurposing.html
https://www.fiercepharma.com/marketing/j-j-sponsored-film-about-first-aids-ward-san-francisco-picked-up-for-broader-distribution
https://endpts.com/going-viral-jj-tries-to-spark-a-twitterstorm-for-the-latest-data-on-its-hiv-med/
https://www.fiercepharma.com/manufacturing/gottlieb-throws-fda-weight-behind-industry-move-to-continuous-manufacturing
http://www.pharmatimes.com/news/nhs_england_agrees_to_fund_janssens_symtuza_1254081
https://www.biopharmadive.com/news/pharmas-slow-embrace-of-continuous-manufacturing/532811/
https://www.biopharmadive.com/news/mercks-virology-business-needs-a-boost-it-may-not-get-that-from-2-new-hiv/531423/
https://endpts.com/jj-joins-blockbuster-hiv-combo-race-with-newly-approved-4-in-1-pill/
https://www.pharmacompass.com/pdf/news/krka-dd-novo-mestos-darunavir-receives-approval-in-europe-1517032602.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206288
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206555
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hetero-launches-fdc-combination-of-key-hiv-drugs/articleshow/61644245.cms
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/11/news_detail_002844.jsp&mid=WC0b01ac058004d5c1
http://www.businesswire.com/news/home/20171025005612/en/Janssen%E2%80%99s-New-Darunavir-Based-Single-Tablet-Regimen-SYMTUZA%C2%AE/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
http://www.prnewswire.com/news-releases/janssen-announces-pivotal-phase-3-study-results-for-investigational-darunavir-based-single-tablet-regimen-for-the-treatment-of-hiv-1-infection-in-adults-switching-from-boosted-protease-inhibitors-plus-emtricitabine-and-tenofovir-d-300532663.html
https://www.pharmacompass.com/pdf/news/janssen-cilag-international-generic-symtuza-receives-approval-in-europe-1506487967.pdf
http://www.prnewswire.com/news-releases/fda-accepts-supplemental-new-drug-application-for-eisais-lenvatinib-for-the-treatment-of-liver-cancer-300526147.html
http://www.pharmatimes.com/news/ec_approves_janssens_symtuza_1206421
https://www.pharmacompass.com/pdf/news/prezista-darunavir-janssen-sciences-ireland-uc-v-aurobindo-pharma-1505212202.pdf
http://www.businesswire.com/news/home/20170725005802/en/Janssen-Announces-Phase-3-Pivotal-Study-Results/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
http://www.in-pharmatechnologist.com/Processing/EMA-clears-Janssen-to-make-HIV-drug-using-continuous-manufacturing-approach
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206555
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process
https://www.pharmacompass.com/pdf/news/mylan-sasgets-eu-nod-for-darunavir-1486203609.pdf
https://www.pharma-excipients.ch/2016/12/20/encapsulating-darunavir-nanocrystals-within-eudragit-l100-using-coaxial-electrospraying/
http://www.in-pharmatechnologist.com/Processing/Continuous-and-aseptic-innovations-top-US-FDA-list-of-emerging-tech
http://www.pharmatimes.com/news/nine_therapies_put_forward_for_eu_approval_1176576
http://www.in-pharmatechnologist.com/Processing/Thermo-provides-hot-melt-tech-to-US-continuous-manufacturing-researchers
Market Place
Share 
